{
    "organizations": [],
    "uuid": "128a42e5563ef5eed12efc6b8ff58874b231cc7e",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-intercept-pharmaceuticals-reports/brief-intercept-pharmaceuticals-reports-q4-net-loss-per-common-potential-common-share-4-43-idUSL8N1Q44TD",
    "ord_in_thread": 0,
    "title": "BRIEF-Intercept Pharmaceuticals Reports Q4 Net Loss Per Common & Potential Common Share $4.43",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 14 (Reuters) - Intercept Pharmaceuticals Inc:\n* INTERCEPT PHARMACEUTICALS REPORTS FULL YEAR AND FOURTH QUARTER 2017 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE\n* REGENERATE TRIAL IN NASH FIBROSIS ON TRACK TO REPORT DATA IN 1H19\n* PROJECTS NON-GAAP ADJUSTED OPERATING EXPENSES OF $390 MILLION TO $410 MILLION FOR FISCAL YEAR ENDING DEC 31, 2018\n* QTRLY NET LOSS PER COMMON AND POTENTIAL COMMON SHARE $4.43\n* Q4 EARNINGS PER SHARE VIEW $-3.55, REVENUE VIEW $39.0 MILLION -- THOMSON REUTERS I/B/E/S\n* Q4 REVENUE $37.7 MILLION Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-14T20:26:00.000+02:00",
    "crawled": "2018-02-15T20:54:28.019+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "intercept",
        "pharmaceutical",
        "inc",
        "intercept",
        "pharmaceutical",
        "report",
        "full",
        "year",
        "fourth",
        "quarter",
        "financial",
        "result",
        "provides",
        "business",
        "update",
        "regenerate",
        "trial",
        "nash",
        "fibrosis",
        "track",
        "report",
        "data",
        "1h19",
        "project",
        "adjusted",
        "operating",
        "expense",
        "million",
        "million",
        "fiscal",
        "year",
        "ending",
        "dec",
        "qtrly",
        "net",
        "loss",
        "per",
        "common",
        "potential",
        "common",
        "share",
        "q4",
        "earnings",
        "per",
        "share",
        "view",
        "revenue",
        "view",
        "million",
        "thomson",
        "reuters",
        "q4",
        "revenue",
        "million",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}